X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13531) 13531
Magazine Article (32) 32
Book / eBook (27) 27
Book Chapter (15) 15
Newsletter (8) 8
Newspaper Article (4) 4
Dissertation (3) 3
Publication (3) 3
Web Resource (3) 3
Conference Proceeding (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12456) 12456
urinary bladder neoplasms - drug therapy (7505) 7505
male (6937) 6937
female (5991) 5991
urinary bladder neoplasms - pathology (4849) 4849
aged (4847) 4847
middle aged (4648) 4648
bladder cancer (4084) 4084
oncology (3724) 3724
cancer (3635) 3635
urology & nephrology (3141) 3141
adult (2472) 2472
carcinoma, transitional cell - drug therapy (2436) 2436
animals (2275) 2275
urinary bladder neoplasms - surgery (2195) 2195
chemotherapy (1997) 1997
antineoplastic combined chemotherapy protocols - therapeutic use (1871) 1871
aged, 80 and over (1847) 1847
urinary bladder neoplasms - therapy (1821) 1821
treatment outcome (1769) 1769
administration, intravesical (1759) 1759
carcinoma (1522) 1522
tumors (1483) 1483
cell line, tumor (1470) 1470
care and treatment (1457) 1457
combined modality therapy (1443) 1443
prognosis (1412) 1412
urology (1403) 1403
urinary bladder neoplasms - metabolism (1382) 1382
carcinoma, transitional cell - pathology (1323) 1323
bladder (1318) 1318
antineoplastic agents - therapeutic use (1302) 1302
urinary bladder neoplasms - genetics (1296) 1296
neoplasm invasiveness (1220) 1220
neoplasm staging (1201) 1201
mice (1198) 1198
cisplatin - administration & dosage (1124) 1124
urinary bladder neoplasms - mortality (1096) 1096
cystectomy (1082) 1082
research (1063) 1063
therapy (1025) 1025
follow-up studies (1021) 1021
transitional-cell carcinoma (1007) 1007
cisplatin (967) 967
expression (965) 965
urothelial carcinoma (965) 965
retrospective studies (961) 961
apoptosis (921) 921
immunotherapy (916) 916
analysis (897) 897
doxorubicin - administration & dosage (848) 848
time factors (846) 846
chemotherapy, adjuvant (836) 836
bcg vaccine - therapeutic use (830) 830
risk factors (823) 823
health aspects (799) 799
urinary bladder (796) 796
antineoplastic agents - administration & dosage (773) 773
carcinoma, transitional cell - surgery (765) 765
urinary bladder neoplasms - radiotherapy (762) 762
urinary bladder neoplasms - diagnosis (746) 746
radical cystectomy (716) 716
drug therapy (715) 715
metastasis (714) 714
bcg vaccine - administration & dosage (712) 712
recurrence (697) 697
urinary-bladder (675) 675
transitional-cell-carcinoma (667) 667
survival (656) 656
prospective studies (634) 634
medicine & public health (632) 632
diagnosis (616) 616
surgery (616) 616
survival rate (610) 610
bacillus-calmette-guerin (606) 606
disease progression (595) 595
disease-free survival (587) 587
apoptosis - drug effects (585) 585
antineoplastic agents - pharmacology (568) 568
deoxycytidine - analogs & derivatives (568) 568
methotrexate - administration & dosage (552) 552
carcinoma, transitional cell - therapy (544) 544
risk (544) 544
radiotherapy (538) 538
immunohistochemistry (537) 537
development and progression (534) 534
dose-response relationship, drug (531) 531
bladder-cancer (529) 529
tumor cells, cultured (529) 529
drug administration schedule (528) 528
cisplatin - therapeutic use (519) 519
progression (519) 519
doxorubicin (513) 513
neoplasm recurrence, local - prevention & control (509) 509
urinary bladder neoplasms (506) 506
survival analysis (504) 504
urinary bladder - pathology (504) 504
methotrexate (491) 491
pharmacology & pharmacy (490) 490
cancer therapies (482) 482
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12235) 12235
Japanese (658) 658
German (293) 293
French (280) 280
Spanish (173) 173
Italian (105) 105
Russian (105) 105
Chinese (82) 82
Polish (24) 24
Danish (10) 10
Hungarian (10) 10
Bulgarian (7) 7
Dutch (5) 5
Portuguese (5) 5
Romanian (5) 5
Turkish (5) 5
Swedish (4) 4
Czech (3) 3
Finnish (3) 3
Hebrew (3) 3
Lithuanian (3) 3
Norwegian (3) 3
Serbian (3) 3
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 4, pp. 677 - 688
...–muscle-invasive bladder cancer (NMIBC) is unknown. Objectives To compare clinical efficacy, immunogenicity, and genetics of BCG Connaught and Tice... 
Urology | BCG Tice | Intravesical drug administration | Flow cytometry | Urinary bladder neoplasms | BCG Connaught | Immunotherapy | Animal | Models | BCG vaccine | Randomized controlled trial | MYCOBACTERIUM-TUBERCULOSIS | SURVIVAL | TOKYO | BOVIS BCG SUBSTRAINS | RISK | MODEL | ZINC | CARCINOMA IN-SITU | GENOME SEQUENCE | UROLOGY & NEPHROLOGY | SUPEROXIDE-DISMUTASE | Carcinoma, Transitional Cell - mortality | Immunotherapy - methods | Prospective Studies | Humans | Middle Aged | BCG Vaccine - classification | Male | Neoplasm Recurrence, Local - mortality | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Statistics, Nonparametric | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Female | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Risk Assessment | Mice, Inbred C57BL | Kaplan-Meier Estimate | Urinary Bladder Neoplasms - drug therapy | Disease-Free Survival | Animals | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Mice | Administration, Intravesical | BCG Vaccine - administration & dosage | BCG Vaccine/classification | Carcinoma, Transitional Cell/pathology | Immunotherapy/methods | Life Sciences | Carcinoma, Transitional Cell/drug therapy | Immunology | Carcinoma, Transitional Cell/mortality | Neoplasm Recurrence, Local/mortality | Urinary Bladder Neoplasms/drug therapy | Neoplasm Recurrence, Local/pathology | Urinary Bladder Neoplasms/pathology | BCG Vaccine/administration & dosage | Urinary Bladder Neoplasms/mortality
Journal Article
Journal Article
Cancer cell, ISSN 1535-6108, 2014, Volume 25, Issue 2, pp. 152 - 165
Muscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variable clinical outcomes and responses to conventional chemotherapy... 
BREAST-CANCER | CELLS | ONCOLOGY | PROGNOSIS | UROTHELIAL CARCINOMA | RADICAL CYSTECTOMY | GENE-EXPRESSION | CLASSIFICATION | MICROARRAYS | P63 | PROGRESSION | CELL BIOLOGY | Receptors, Estrogen - metabolism | Urinary Bladder Neoplasms - classification | Cell Proliferation | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Muscle Neoplasms - pathology | Muscle Neoplasms - classification | Male | Gene Expression Profiling | Vinblastine - administration & dosage | PPAR gamma - metabolism | Receptor, Fibroblast Growth Factor, Type 3 - metabolism | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Urinary Bladder Neoplasms - pathology | Female | Neoadjuvant Therapy | Cell Differentiation | Muscle Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | PPAR gamma - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Receptors, Estrogen - genetics | Neoplasm Invasiveness | RNA, Messenger - genetics | Carcinoma, Basal Cell - pathology | Urinary Bladder Neoplasms - drug therapy | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Resistance, Neoplasm - genetics | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Basal Cell - drug therapy | Methotrexate - administration & dosage | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Clinical Trials, Phase II as Topic | Cohort Studies | Chemotherapy | Anthracyclines | Estrogen | Methotrexate | Tumor proteins | Bladder cancer | Cancer
Journal Article
EMBO molecular medicine, ISSN 1757-4684, 2014, Volume 6, Issue 10, pp. 1279 - 1293
.... Here, we derived a method for universal EMT scoring from cancer‐specific transcriptomic EMT signatures of ovarian, breast, bladder, lung, colorectal and gastric cancers... 
drug response | microarray | gene expression signature | epithelial‐mesenchymal transition | prognosis | Drug response | Epithelial-mesenchymal transition | Prognosis | Microarray | Gene expression signature | MOLECULAR SUBTYPES | MEDICINE, RESEARCH & EXPERIMENTAL | GENE-EXPRESSION SIGNATURE | STEM-CELLS | GENOMIC ANALYSES | OVARIAN-CANCER | NEGATIVE BREAST-CANCER | CLINICAL-RELEVANCE | MICRORNA CONTROL | CLAUDIN-LOW | epithelial-mesenchymal transition | SIGNATURE PREDICTS RESISTANCE | Lung Neoplasms - drug therapy | Oligonucleotide Array Sequence Analysis | Colorectal Neoplasms - genetics | Humans | Epithelial-Mesenchymal Transition - drug effects | Antineoplastic Agents - therapeutic use | Epithelial-Mesenchymal Transition - genetics | Ovarian Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Neoplasms - genetics | Colorectal Neoplasms - drug therapy | Female | Gene Expression Regulation, Neoplastic - drug effects | Ovarian Neoplasms - drug therapy | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Treatment Outcome | Transcriptome - drug effects | Transcriptome - genetics | Stomach Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - genetics | Cell Line, Tumor | Cancer patients | Chemotherapy | Patient outcomes | Stem cells | Development and progression | Drug therapy | Gene expression | Ovarian cancer | Cancer | Mesenchyme | Colorectal carcinoma | Genomes | Breast cancer | Metastasis | Kinases | Cancer therapies | Metastases | Breast carcinoma | Genotype & phenotype | Paclitaxel | Breast | Software | Tumors
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 1, pp. 142 - 150
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 11/2017, Volume 99, Issue 4, pp. 1039 - 1047
Journal Article
by Weinstein, John N and Akbani, Rehan and Broom, Bradley M and Wang, Wenyi and Verhaak, Roeland G. W and McConkey, David and Lerner, Seth and Morgan, Margaret and Creighton, Chad J and Smith, Carolyn and Cherniack, Andrew D and Kim, Jaegil and Pedamallu, Chandra Sekhar and Noble, Michael S and Al-Ahmadie, Hikmat A and Reuter, Victor E and Rosenberg, Jonathan E and F.Bajorin, Dean and Bochner, Bernard H and Solit, David B and Koppie, Theresa and Robinson, Brian and Gordenin, Dmitry A and Fargo, David and Klimczak, Leszek J and Roberts, Steven A and Au, Jessie and Laird, Peter W and Hinoue, Toshinori and Schultz, Nikolaus and Ramirez, Ricardo and Hansel, Donna and Hoadley, Katherine A and Kim, William Y and Damrauer, Jeffrey S and Baylin, Stephen B and Mungall, Andrew J and Robertson, A. Gordon and Chu, Andy and Kwiatkowski, David J and Sougnez, Carrie and Cibulskis, Kristian and Lichtenstein, Lee and Sivachenko, Andrey and Stewart, Chip and Lawrence, Michael S and Getz, Gad and Lander, Eric and Gabrie, Stacey B and Donehower, Lawrence and Carter, Scott L and Saksena, Gordon and Schumacher, Steven E and Freeman, Samuel S and Jung, Joonil and Bhatt, Ami S and Pugh, Trevor and Beroukhim, Rameen and Meyerson, Matthew and Ally, Adrian and Balasundaram, Miruna and Butterfield, Yaron S. N and Dhalla, Noreen and Hirst, Carrie and Holt, Robert A and Jones, Steven J. M and Lee, Darlene and Li, Haiyan I and Marra, Marco A and Mayo, Michael and Moore, Richard A and Schein, Jacqueline E and Sipahimalani, Payal and Tam, Angela and Thiessen, Nina and Wong, Tina and Wye, Natasja and Bowlby, Reanne and Chuah, Eric and Guin, Ranabir and Shen, Hui and Bootwalla, Moiz S and Triche Jr, Timothy and Lai, Phillip H and Van Den Berg, David J and Weisenberger, Daniel J and Balu, Saianand and Bodenheimer, Tom and Hoyle, Alan P and Jefferys, Stuart R and Meng, Shaowu and Mose, Lisle E and Simons, Janae V and Soloway, Mathew G and Wu, Junyuan and Parker, Joel S and Hayes, D. Neil and Roach, Jeffrey and Buda, Elizabeth and Jones, Corbin D and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Nature (London), ISSN 1476-4687, 2014, Volume 507, Issue 7492, pp. 315 - 322
Journal Article